Viewing Study NCT01578668


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2025-12-28 @ 12:30 AM
Study NCT ID: NCT01578668
Status: COMPLETED
Last Update Posted: 2015-01-26
First Post: 2012-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Sponsor: Guangzhou Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Adenocarcinoma View
None Brain Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None lung adenocarcinoma View
None brain metastases View
None erlotinib View
None pemetrexed View